544013 Stock Overview
Provides healthcare services in India. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 2/6 |
KK Shah Hospitals Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹46.80 |
52 Week High | ₹89.80 |
52 Week Low | ₹37.50 |
Beta | 0 |
11 Month Change | 1.52% |
3 Month Change | -6.87% |
1 Year Change | -36.03% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -20.54% |
Recent News & Updates
Recent updates
Shareholder Returns
544013 | IN Healthcare | IN Market | |
---|---|---|---|
7D | -3.7% | -2.3% | -3.4% |
1Y | -36.0% | 36.8% | 27.0% |
Return vs Industry: 544013 underperformed the Indian Healthcare industry which returned 36.8% over the past year.
Return vs Market: 544013 underperformed the Indian Market which returned 27% over the past year.
Price Volatility
544013 volatility | |
---|---|
544013 Average Weekly Movement | 15.7% |
Healthcare Industry Average Movement | 5.9% |
Market Average Movement | 6.2% |
10% most volatile stocks in IN Market | 9.2% |
10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 544013's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: 544013's weekly volatility has increased from 10% to 16% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1976 | 69 | Amit Shah | www.shahhospitalratlam.com |
KK Shah Hospitals Limited provides healthcare services in India. The company operates a hospital that offers services in the areas of general surgery, orthopaedics, obstetrics and gynecology, dental, general medicine, pediatrics, radiology, and physiotherapy. The company was formerly known as Jeevan Parv Healthcare Limited and changed its name to KK Shah Hospitals Limited in September 2022.
KK Shah Hospitals Limited Fundamentals Summary
544013 fundamental statistics | |
---|---|
Market cap | ₹318.64m |
Earnings (TTM) | ₹7.39m |
Revenue (TTM) | ₹75.71m |
43.1x
P/E Ratio4.2x
P/S RatioIs 544013 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
544013 income statement (TTM) | |
---|---|
Revenue | ₹75.71m |
Cost of Revenue | ₹18.45m |
Gross Profit | ₹57.27m |
Other Expenses | ₹49.87m |
Earnings | ₹7.39m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 1.09 |
Gross Margin | 75.63% |
Net Profit Margin | 9.76% |
Debt/Equity Ratio | 0% |
How did 544013 perform over the long term?
See historical performance and comparison